Akorn to Use Voluntary Chapter 11 Process to Position Business for Long-Term Success [PR Newswire] PR NewswireMay 20, 2020
Continues Operations as Usual, Delivering Safe and Effective Products to Customers and Patients
LAKE FOREST, Ill., May 20, 2020 /PRNewswire/ -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty pharmaceutical company ("Akorn" or the "Company"), today announced that the Company and its U.S. subsidiaries filed for voluntary protection under Chapter 11 ("Chapter 11") of the U.S. Bankruptcy Code in United States Bankruptcy Court for the
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.